Evolus Logo Nov 2018.png
Evolus Reports First Quarter 2021 Results and Provides Business Update
May 12, 2021 16:05 ET | Evolus
Q1 2021 Net Revenues of $12.2 million, Despite Half-Quarter ITC Impact Full Resolution of International Trade Commission (ITC) Case Restructured Balance Sheet with March 31, 2021 Pro Forma Cash...
Evolus Logo Nov 2018.png
Aesthetic Surgery Journal Publishes Long Term Safety and Efficacy Data of Jeuveau® for the Treatment of Moderate to Severe Frown Lines
May 12, 2021 09:00 ET | Evolus
NEWPORT BEACH, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Logo Nov 2018.png
Evolus to Report First Quarter 2021 Results and Provide Business Update
May 04, 2021 16:05 ET | Evolus
NEWPORT BEACH, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus to Participate in the 7th Annual Truist Securities Life Sciences Summit
April 29, 2021 16:05 ET | Evolus
NEWPORT BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Announces Pricing of Public Offering of Common Stock
April 21, 2021 22:30 ET | Evolus
NEWPORT BEACH, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) announced today the pricing of its public offering of 9,000,000 shares of its common stock at a public offering...
Evolus Logo Nov 2018.png
Evolus Announces Proposed Public Offering of Common Stock
April 21, 2021 16:01 ET | Evolus
NEWPORT BEACH, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS) announced today that it has commenced a proposed underwritten public offering, subject to market and other...
Evolus Logo Nov 2018.png
Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business Update
March 24, 2021 16:05 ET | Evolus
Q4 2020 Net Revenue $20.6 Million, Highest Net Revenue Quarter Since Launch of Jeuveau® Pro Forma Cash Position of $57 Million at December 31, 20201 NEWPORT BEACH, Calif., March 24, 2021 ...
Evolus Logo Nov 2018.png
Evolus to Report Fourth Quarter and Year End 2020 Results and Provide Business Update
March 23, 2021 09:21 ET | Evolus
NEWPORT BEACH, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Logo Nov 2018.png
Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elimination of $127.4 Million of Debt and Milestone Payments
March 23, 2021 09:17 ET | Evolus
Pro Forma Cash Position of $57 Million at December 31, 20201 NEWPORT BEACH, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a...
Evolus Logo Nov 2018.png
Evolus to Participate in Two Upcoming Investor Conferences
March 02, 2021 16:05 ET | Evolus
NEWPORT BEACH, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...